These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6740732)

  • 1. Half-life prediction in unstable renal function: its utility in therapeutic drug monitoring and theoretical and practical considerations.
    Chow MS
    Ther Drug Monit; 1984; 6(2):148-52. PubMed ID: 6740732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosage schedule of gentamicin for chronic renal insufficiency in children.
    Yoshioka H; Takimoto M; Matsuda I; Hattori S
    Arch Dis Child; 1978 Apr; 53(4):334-7. PubMed ID: 646447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining gentamicin dosage in infants and children with renal failure.
    Sirinavin S; McCracken GH; Nelson JD
    J Pediatr; 1980 Feb; 96(2):331-4. PubMed ID: 7351608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple method for the estimation of glomerular filtration rate by gentamicin pharmacokinetics during routine drug monitoring in the newborn.
    Koren G; James A; Perlman M
    Clin Pharmacol Ther; 1985 Dec; 38(6):680-5. PubMed ID: 4064469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gentamicin therapy in renal failure: a nomogram for dosage.
    Chan RA; Benner EJ; Hoeprich PD
    Ann Intern Med; 1972 May; 76(5):773-8. PubMed ID: 4623584
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of four methods of predicting serum gentamicin concentrations in adult patients with impaired renal function.
    Platt DR; Matthews SJ; Sevka MJ; Comer JB; Quintiliani R; Cunha BA; Nightingale CH; Chow MS
    Clin Pharm; 1982; 1(4):361-5. PubMed ID: 7185531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is endogenous creatinine clearance a sound basis for estimation of elimination half life of gentamicin?].
    Rameis H; Hitzenberger G; Jaschek I; Graninger W
    Dtsch Med Wochenschr; 1980 Nov; 105(47):1650-4. PubMed ID: 7439047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic adjustment of gentamicin dosing in horses with sepsis.
    Sojka JE; Brown SA
    J Am Vet Med Assoc; 1986 Oct; 189(7):784-9. PubMed ID: 3771340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between nephrotoxicity and pharmacokinetic parameters of gentamicin.
    el-Sayed YM
    J Clin Pharm Ther; 1994 Aug; 19(4):267-71. PubMed ID: 7989408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial dosage regimens of gentamicin in patients with burns.
    Zaske DE; Chin T; Kohls PR; Solem LD; Strate RG
    J Burn Care Rehabil; 1991; 12(1):46-50. PubMed ID: 2022681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of gentamicin dosing according to renal function in neonates with suspected sepsis.
    Reimche LD; Rooney ME; Hindmarsh KW; Gorecki DK; Remillard AJ; Sankaran K
    Am J Perinatol; 1987 Jul; 4(3):262-5. PubMed ID: 3606761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gentamicin dosage regimen based on serum creatinine concentration.
    Malvino E; Goldenberg D; Giniger R; Casabella A; Jorge M
    Chemotherapy; 1987; 33(5):316-21. PubMed ID: 3665629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue persistence of gentamicin in man.
    Schentag JJ; Jusko WJ; Plaut ME; Cumbo TJ; Vance JW; Abrutyn E
    JAMA; 1977 Jul; 238(4):327-9. PubMed ID: 406431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid gentamicin elimination in obstetric patients.
    Zaske DE; Cipolle RJ; Strate RG; Malo JW; Koszalka MF
    Obstet Gynecol; 1980 Nov; 56(5):559-64. PubMed ID: 7432725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.
    Goetz DR; Pancorbo S; Hoag S; Bloom P
    Am J Hosp Pharm; 1980 Aug; 37(8):1077-83. PubMed ID: 7405935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental pattern of gentamicin kinetics in very low birth weight (VLBW) sick infants.
    Kildoo C; Modanlou HD; Komatsu G; Harralson A; Hodding J
    Dev Pharmacol Ther; 1984; 7(6):345-56. PubMed ID: 6518943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gentamicin kinetics in the neonate.
    Miranda JC; Schimmel MM; James LS; Spinelli W; Rosen TS
    Pediatr Pharmacol (New York); 1985; 5(1):57-61. PubMed ID: 3991253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The performances of the Cockcroft-Gault, modification of diet in renal disease study and chronic kidney disease epidemiology collaboration equations in predicting gentamicin clearance.
    Chin PK; Florkowski CM; Begg EJ
    Ann Clin Biochem; 2013 Nov; 50(Pt 6):546-57. PubMed ID: 24045301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with a method for adjusting gentamicin dose from measured drug clearance.
    Davey PG; Geddes AM; Gonda I; Harpur ES; Scott DK
    J Antimicrob Chemother; 1983 Dec; 12(6):613-22. PubMed ID: 6662839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictability of blood levels of gentamicin in man.
    Barza M; Brown RB; Shen D; Gibaldi M; Weinstein L
    J Infect Dis; 1975 Aug; 132(2):165-74. PubMed ID: 808583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.